Global Medical Information

Novavax Medical Information

DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN Czech Republic ONLY.

If you are NOT a Healthcare Professional in Czech Republic, please switch to the Consumer Medical Information page.

Medical Information
Adverse Event Reporting
Product Quality Complaint

Information on the NuvaxovidTM JN.1▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

If your enquiry is regarding the NuvaxovidTM JN.1▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted), you can find some useful information in the resources below.

Nuvaxovid JN.1 Summary of Product Characteristics (SmPC)
Download PDF
Nuvaxovid JN.1▼ Product Information Leaflet (PIL)
Download PDF

Request Medical Information

Healthcare Professionals may request medical information via ONE of the following ways:

Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.

Request Medical Information

Option 2: Call +420 228 880 267 between 09:00-17:00.

Report an Adverse Event (AE)

If you are concerned about an adverse event, it should be reported to the State Institute for Drug Control (SUKL) at http://www.sukl.cz.

Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +420 228 880 267 or via the Novavax Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +420 228 880 267 between 09:00-17:00.